CJC-1295 with Drug Affinity Complex (DAC) is a long-acting GHRH analogue engineered for extended plasma half-life through covalent binding to endogenous albumin via the maleimidoproprionic acid (MPA) linker. This modification extends the biological activity from minutes to days compared to native GHRH, enabling sustained elevation of GH and IGF-1 levels in research models. It is most commonly studied in combination with Ipamorelin for synergistic GH axis stimulation. Batch 2026/02 verified at 99.75% average purity, range 99.71–99.78%.
Recommended diluent: Bacteriostatic Water (0.9% benzyl alcohol)
Add 1mL of bacteriostatic water to the 5mg vial, directing liquid slowly down the glass wall. Swirl gently until dissolved. Resulting concentration: 5mg/mL.
CJC-1295 w/DAC may be stored at 2–8°C for up to 28 days after reconstitution. Due to its extended half-life, less frequent administration is typically studied in protocols versus non-DAC variants.